The IMOMA is a private initiative of the Masaveu Corporation, Cajastur and Asturian Medicine to fight against cancer.
Its healthcare activity is based on three pillars: coordinated, updated and personalized patient care, the integration of advances in molecular biology into clinical protocols, and a commitment to state-of-the-art radiotherapy.

Specialized in ophthalmology care activities, attending each year approximately 100,000 patients, of whom 65,000 come from outside Asturias.
At the same time, it carries out clinical research to make continuous improvements and incorporate new treatments and products in the field of ophthalmology and vision sciences, based on R&D&i projects.

The Bayer acetylsalicylic acid plant in Asturias is where 100 % of the active
ingredient for Aspirin is produced. Some 200 million units of aspirin are consumed around the world each day.
Additionally, and as a result of its high levels of competitiveness, experience and quality, the Bayer plant in Asturias, plans to take on the worldwide production of an active ingredient for an anti-parasitic drug for pets.